Oshadi Drug Administration

• Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study

  Phase 2, Completed, 12 people, 1 Nov 2013

• Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study

  Phase 1/2, Completed, 10 people, 21 Jan 2013

Sources: clinicaltrials.gov